BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26874306)

  • 1. In vitro and in vivo identification of tetradentated polyamine complexes as highly efficient metallodrugs against Trypanosoma cruzi.
    Olmo F; Cussó O; Marín C; Rosales MJ; Urbanová K; Krauth-Siegel RL; Costas M; Ribas X; Sánchez-Moreno M
    Exp Parasitol; 2016 May; 164():20-30. PubMed ID: 26874306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro iron superoxide dismutase inhibitor decreases the parasitemia levels of Trypanosoma cruzi in BALB/c mouse model during acute phase.
    Olmo F; Urbanová K; Rosales MJ; Martín-Escolano R; Sánchez-Moreno M; Marín C
    Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):110-6. PubMed ID: 26236582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetradentate polyamines as efficient metallodrugs for Chagas disease treatment in murine model.
    Olmo F; Costas M; Marín C; Rosales MJ; Martín-Escolano R; Cussó O; Gutierrez-Sánchez R; Ribas X; Sánchez-Moreno M
    J Chemother; 2017 Apr; 29(2):83-93. PubMed ID: 27251893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanothione Reductase and Superoxide Dismutase as Current Drug Targets for Trypanosoma cruzi: An Overview of Compounds with Activity against Chagas Disease.
    Beltran-Hortelano I; Perez-Silanes S; Galiano S
    Curr Med Chem; 2017 May; 24(11):1066-1138. PubMed ID: 28025938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo trypanosomicidal activity of pyrazole-containing macrocyclic and macrobicyclic polyamines: their action on acute and chronic phases of Chagas disease.
    Sánchez-Moreno M; Marín C; Navarro P; Lamarque L; García-España E; Miranda C; Huertas O; Olmo F; Gómez-Contreras F; Pitarch J; Arrebola F
    J Med Chem; 2012 May; 55(9):4231-43. PubMed ID: 22443115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospects of an alternative treatment against Trypanosoma cruzi based on abietic acid derivatives show promising results in Balb/c mouse model.
    Olmo F; Guardia JJ; Marin C; Messouri I; Rosales MJ; Urbanová K; Chayboun I; Chahboun R; Alvarez-Manzaneda EJ; Sánchez-Moreno M
    Eur J Med Chem; 2015 Jan; 89():683-90. PubMed ID: 25462275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phthalazine derivatives containing imidazole rings behave as Fe-SOD inhibitors and show remarkable anti-T. cruzi activity in immunodeficient-mouse mode of infection.
    Sánchez-Moreno M; Gómez-Contreras F; Navarro P; Marín C; Olmo F; Yunta MJ; Sanz AM; Rosales MJ; Cano C; Campayo L
    J Med Chem; 2012 Nov; 55(22):9900-13. PubMed ID: 23043291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro and in Vivo Anti-Trypanosoma cruzi Activity of New Arylamine Mannich Base-Type Derivatives.
    Moreno-Viguri E; Jiménez-Montes C; Martín-Escolano R; Santivañez-Veliz M; Martin-Montes A; Azqueta A; Jimenez-Lopez M; Zamora Ledesma S; Cirauqui N; López de Ceráin A; Marín C; Sánchez-Moreno M; Pérez-Silanes S
    J Med Chem; 2016 Dec; 59(24):10929-10945. PubMed ID: 28002965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-parasitic effect of vitamin C alone and in combination with benznidazole against Trypanosoma cruzi.
    Puente V; Demaria A; Frank FM; Batlle A; Lombardo ME
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006764. PubMed ID: 30240395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of in vitro and in vivo trypanocidal properties of a new imidazole-containing nitrophthalazine derivative.
    Olmo F; Gómez-Contreras F; Navarro P; Marín C; Yunta MJ; Cano C; Campayo L; Martín-Oliva D; Rosales MJ; Sánchez-Moreno M
    Eur J Med Chem; 2015 Dec; 106():106-19. PubMed ID: 26523668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scorpiand-like azamacrocycles prevent the chronic establishment of Trypanosoma cruzi in a murine model.
    Olmo F; Marín C; Clares MP; Blasco S; Albelda MT; Soriano C; Gutiérrez-Sánchez R; Arrebola-Vargas F; García-España E; Sánchez-Moreno M
    Eur J Med Chem; 2013; 70():189-98. PubMed ID: 24158012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentamidine antagonizes the benznidazole's effect in vitro, and lacks of synergy in vivo: Implications about the polyamine transport as an anti-Trypanosoma cruzi target.
    Seguel V; Castro L; Reigada C; Cortes L; Díaz MV; Miranda MR; Pereira CA; Lapier M; Campos-Estrada C; Morello A; Kemmerling U; Maya JD; López-Muñoz R
    Exp Parasitol; 2016 Dec; 171():23-32. PubMed ID: 27729250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple dialkyl pyrazole-3,5-dicarboxylates show in vitro and in vivo activity against disease-causing trypanosomatids.
    Reviriego F; Olmo F; Navarro P; Marín C; Ramírez-Macías I; García-España E; Albelda MT; Gutiérrez-Sánchez R; Sánchez-Moreno M; Arán VJ
    Parasitology; 2017 Aug; 144(9):1133-1143. PubMed ID: 28367781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of new long-chain squaramides as anti-chagasic agents in the BALB/c mouse model.
    Martín-Escolano R; Marín C; Vega M; Martin-Montes Á; Medina-Carmona E; López C; Rotger C; Costa A; Sánchez-Moreno M
    Bioorg Med Chem; 2019 Mar; 27(5):865-879. PubMed ID: 30728107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity in vitro and in vivo against Trypanosoma cruzi of a furofuran lignan isolated from Piper jericoense.
    García-Huertas P; Olmo F; Sánchez-Moreno M; Dominguez J; Chahboun R; Triana-Chávez O
    Exp Parasitol; 2018 Jun; 189():34-42. PubMed ID: 29656102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational modification of Mannich base-type derivatives as novel antichagasic compounds: Synthesis, in vitro and in vivo evaluation.
    Paucar R; Martín-Escolano R; Moreno-Viguri E; Azqueta A; Cirauqui N; Marín C; Sánchez-Moreno M; Pérez-Silanes S
    Bioorg Med Chem; 2019 Sep; 27(17):3902-3917. PubMed ID: 31345745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo trypanocidal activity of some benzimidazole derivatives against two strains of Trypanosoma cruzi.
    Díaz-Chiguer DL; Márquez-Navarro A; Nogueda-Torres B; de la Luz León-Ávila G; Pérez-Villanueva J; Hernández-Campos A; Castillo R; Ambrosio JR; Nieto-Meneses R; Yépez-Mulia L; Hernández-Luis F
    Acta Trop; 2012 Apr; 122(1):108-12. PubMed ID: 22212465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting polyamine transport in Trypanosoma cruzi.
    Reigada C; Phanstiel O; Miranda MR; Pereira CA
    Eur J Med Chem; 2018 Mar; 147():1-6. PubMed ID: 29421567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and 2D-QSAR studies of neolignan-based diaryl-tetrahydrofuran and -furan analogues with remarkable activity against Trypanosoma cruzi and assessment of the trypanothione reductase activity.
    Hartmann AP; de Carvalho MR; Bernardes LSC; Moraes MH; de Melo EB; Lopes CD; Steindel M; da Silva JS; Carvalho I
    Eur J Med Chem; 2017 Nov; 140():187-199. PubMed ID: 28926763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of N,N'-squaramides with high in vivo efficacy and low toxicity: toward a low-cost drug against Chagas disease.
    Olmo F; Rotger C; Ramírez-Macías I; Martínez L; Marín C; Carreras L; Urbanová K; Vega M; Chaves-Lemaur G; Sampedro A; Rosales MJ; Sánchez-Moreno M; Costa A
    J Med Chem; 2014 Feb; 57(3):987-99. PubMed ID: 24410674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.